| GlucoTrack is a medical device company focused on the design, development and commercialization of non-invasive glucose monitoring devices for use by people with diabetes and pre-diabetics. Co. has developed a non-invasive glucose monitor, the GlucoTrack® glucose monitoring device, which is designed to help people with diabetes and pre-diabetics obtain glucose level readings. The GlucoTrack utilizes a combination of ultrasound, electromagnetic and thermal technologies to obtain glucose measurements via a sensor that is clipped onto one's earlobe and connected to a handheld control and display unit without drawing blood or interstitial fluid. The GCTK average annual return since 2013 is shown above.
The Average Annual Return on the GCTK average annual return since 2013 page and across the coverage universe of our site,
is a measure of the annualized return over the past ten years (or specified start date) for a given investment
(up to the end of prior trading session recorded). Arguably, choosing ten years for a measurement
period is on the one hand completely arbitrary, but on the other hand provides a sufficiently long window
to capture long-term trends.
Thus, researching Average Annual Returns is good practice for investors — whether GCTK average annual return since 2013 or other benchmarks/peers
— and when doing so it is also important to factor in dividends, because a financial instrument's annualized return is
more than just the change in price if that instrument pays a dividend or coupon. Our website aims to empower investors
by performing the GCTK average annual return calculation with any dividends reinvested as applicable (on ex-dates).